×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Lung Cancer

Beth Fand Incollingo
Precision medicine has prolonged life for many with lung cancer, giving them opportunities to support those who are newly diagnosed.
Alvin David, B.S.N., RN-BC
"Alvin David, B.S.N., RN-BC, wrote this exemplar as part of his promotion to clinical nurse 3. I will let his words do the talking, as they reveal his true essence as a nurse, colleague, preceptor, friend, father, husband and extraordinary healer," wrote Margie McDonald, M.S.N., RN, CBCN of Memorial Sloan Kettering Monmouth.
Katie Kosko and Brielle Benyon
We've got a sneak peek at what’s inside CURE®'s lung cancer special issue.
Katie Kosko
With nearly 30 years of experience in thoracic oncology, one expert discusses what lies ahead for patients with small cell lung cancer.
Samantha Mixon
I have stage 4 lung cancer and told I had 12-18 months to live. Little did I know they sent a biopsy off for genome testing which has given me six years so far. My life is incredibly imperfect, but I love every single minute of it.
Kayla Haskins
LUNGevity’s annual summit helps people with lung cancer live better and stay informed.
Katie Kosko
Thousands of new patients are now able to enroll in Lung Cancer Master Cancer Protocol, a National Cancer Institute trial. Criteria have been expanded to allow patients with all types of non-small cell lung cancer.
Dara Chadwick
Two husbands embrace changing and challenging roles at home when they learn of their spouses’ cancer diagnoses.
Marilyn Fenichel
A pre-surgical shape-up could improve recovery for patients with lung cancer. Although the findings are still emerging, some researchers think that prehab may be a key player that will improve patient outcomes in this changing environment.
Arlene Weintraub
Testing for genomic mutations in lung cancer helps pinpoint targeted therapies.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other